Trujillo de la Fuente Korely, López Goméz Jesús, Cortes Espinosa Tomas, Perez-Cabeza de Vaca Rebeca, Paredes Amenabar Carlos, Romero Lozania Jose, Navarro-Gerrard Megan, Mateos Viramontes Ana Luisa, Ramos Gómez Mayra
ISSSTE Centro Médico Nacional 20 de Noviembre, Ciudad de México, Mexico.
INNSZ, Ciudad de México, Mexico.
Am J Gastroenterol. 2021 Dec 1;116(Suppl 1):S16. doi: 10.14309/01.ajg.0000798844.44337.f4.
Sleep disorders occur recurrently in patients with inflammatory bowel disease (IBD). The relationship between poor sleep quality and IBD activity has been subject to scarce attention. Poor sleep quality could be considered a relevant extraintestinal manifestation and a potential marker of subclinical inflammation, which could increase the severity of inflammation and the risk of relapse, however, we do not have enough information to confirm this hypothesis. Objective: Describe the impact of IBD on the quality of sleep, in patients treated in a referral hospital.
Observational, analytical, and cross-sectional study. Patients with diagnosis of IBD treated at Centro Médico Nacional "20 de Noviembre" were evaluated. The Pittsburgh Sleep Quality Index (PSQI) was used to measure sleep quality. IBD activity was measured using the Harvey-Bradshaw index for Crohn's disease (CD) and the Mayo scale for Ulcerative Colitis (UC).
A total of 51 patients were included, the Pittsburgh Sleep Index Questionnaire (PSQI) was performed, after informed consent was signed. Patients had a mean age of 52. Fifty five percent were female, 65% had UC. Biological therapy was administered to 70.5%. In CD 89% were in remission and 11% in moderate activity. In UC 48.5% were in remission, 45.5% had mild activity and 6% had moderate activity. Eighty percent of the patients did not use hypnotic drugs. Patients with UC in remission had a bad perception of sleep quality in 68%, quite good sleep quality in 18% and very good sleep quality in 12% with a PSQI of 10.5 ± 3.2. In patients with mild activity, the perception of sleep quality was very good in 6%, quite good in 46%, quite bad in 40% and very bad in 6%, with a PSQI of 8 ± 3.7. In patients with moderate activity, 100% had a rather bad perception of sleep quality with a PSQI of 11 ± 1.4. For CD in remission the perception of sleep was quite bad in 43%, quite good in 43%, very bad in 6% and very good in 6% with a PSQI of 9 ± 4.3. In patients with moderate activity 50% had a very bad sleep quality perception and 50% a fairly good sleep quality perception with a PSQI of 14 ± 4.2.
In this study a statistically significant association was obtained between PSQI and the perception of sleep reported by the patients, with a p < 0.005. Further research is still needed to better characterize sleep disturbances in this population. Due to the sample size, a prospective, randomized study is required to confirm these findings. The present analysis has no conflict of interest.
炎症性肠病(IBD)患者经常出现睡眠障碍。睡眠质量差与IBD活动之间的关系很少受到关注。睡眠质量差可被视为一种相关的肠外表现和亚临床炎症的潜在标志物,这可能会增加炎症的严重程度和复发风险,然而,我们没有足够的信息来证实这一假设。目的:描述IBD对一家转诊医院接受治疗的患者睡眠质量的影响。
观察性、分析性和横断面研究。对在国家医学中心“11月20日”接受治疗的IBD诊断患者进行评估。使用匹兹堡睡眠质量指数(PSQI)来测量睡眠质量。使用克罗恩病(CD)的哈维-布拉德肖指数和溃疡性结肠炎(UC)的梅奥量表来测量IBD活动。
共纳入51例患者,在签署知情同意书后进行了匹兹堡睡眠指数问卷(PSQI)调查。患者的平均年龄为52岁。55%为女性,65%患有UC。70.5%的患者接受了生物治疗。在CD患者中,89%处于缓解期,11%处于中度活动期。在UC患者中,48.5%处于缓解期,45.5%有轻度活动,6%有中度活动。80%的患者未使用催眠药物。缓解期的UC患者中,68%对睡眠质量的感知较差,18%睡眠质量相当好,12%睡眠质量非常好,PSQI为10.5±3.2。轻度活动的患者中,6%对睡眠质量的感知非常好,46%相当好,40%相当差,6%非常差,PSQI为8±3.7。中度活动的患者中,100%对睡眠质量的感知相当差,PSQI为11±1.4。对于缓解期的CD患者,43%对睡眠的感知相当差,43%相当好,6%非常差,6%非常好,PSQI为9±4.3。中度活动的患者中,50%对睡眠质量的感知非常差,50%相当好,PSQI为14±4.2。
在本研究中,PSQI与患者报告的睡眠感知之间获得了具有统计学意义的关联,p<0.005。仍需要进一步研究以更好地描述该人群的睡眠障碍特征。由于样本量的原因,需要进行一项前瞻性、随机研究来证实这些发现。本分析不存在利益冲突。